Geffy 250 Mg Tablet

Name: Geffy 250 Mg Tablet
Brand: Maheshwari Medical Agency
Price: 600 INR
Availability: InStock

Price 600 INR/ Strip

Get a Price/Quote

MOQ : 3 Strips

Geffy 250 Mg Tablet Specification

Indication
Non-Small Cell Lung Cancer (NSCLC)

Origin
India

Dosage Form
Tablets

Salt Composition
Gefitinib 250 mg

Enzyme Types
Tyrosine Kinase Inhibitor

Feature
Targeted therapy, Oral administration

Ingredients
Other

Application
Other

Ph Level
Neutral

Physical Color/Texture
Light brown, round, film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits EGFR-TK enzymatic activity

Storage Instructions
Keep dry & cool place

Shelf Life
24 months

Batch Number
As on pack

Warning & Precautions
Liver and kidney impairment, pregnant and lactating women should consult their doctor.

Side Effects
Rash, diarrhea, nausea, vomiting, loss of appetite

Contraindication
Hypersensitivity to gefitinib

Strength
250 mg per tablet

Packaging Type
Blister Pack

Administration Route
Oral

Pack Size
30 Tablets per pack

Product Category
Oncology

Prescription Requirement
Prescription Only

Approved By
DCGI (India)

Geffy 250 Mg Tablet Trade Information

Minimum Order Quantity
3 Strips

Supply Ability
100 Strips Per Week

Delivery Time
7 Days

About Geffy 250 Mg Tablet

Geffy 250 Mg Tablet is an eminent tyrosine kinase inhibitor, meticulously formulated for targeted oncology therapy, specifically Non-Small Cell Lung Cancer (NSCLC). Approved by DCGI India and crafted with superlative precision in India, each elite, light brown, round, film-coated tablet contains 250 mg gefitinib. Highly recommended by leading oncologists, Geffy comes in a convenient blister pack of 30 for easy administration. With limited stock available, secure your pack today! Purchase requires a prescription. Store in a dry, cool environment for optimal shelf life. Experience advanced, odorless, and effective cancer care.

Superior Features and Additional Applications

Apart from its primary indication in NSCLC, Geffy 250 Mg Tablet boasts remarkable material stability and efficacy, with a neutral pH and superior film-coating for consistent dosing. Its targeted therapy minimizes broader cellular damage, focusing its enzymatic activity exclusively on inhibiting EGFR-TK. Manufactured with eminent quality standards, the product's compliance with international oncology medication norms renders it ideal for elite clinical environments addressing complex cancer cases.

Sample Policy, Shipping, and Exportation Insight

Our supply process for Geffy 250 Mg Tablet samples is prompt and responsive, offering quotations tailored to client expenditure. Shipments depart via major FOB Indian ports, ensuring global reach. Whether you are a distributor, supplier, or trader, our streamlined export mechanism serves main international markets with reliability. Requests for product samples, supply agreements, or detailed quotations are handled adeptly to optimize both value and delivery timelines for all stakeholders.

FAQ's of Geffy 250 Mg Tablet:

Q: How should Geffy 250 Mg Tablet be taken for optimal efficacy?

A: Geffy 250 Mg Tablet should be ingested orally as per your doctor's advice, ideally at the same time each day, to maintain consistent blood levels. Adherence to prescribed dosage is essential for best therapeutic results.

Q: What are the main side effects associated with Geffy 250 Mg Tablet?

A: Common side effects include rash, diarrhea, nausea, vomiting, and loss of appetite. If you experience severe discomfort, consult your healthcare provider promptly.

Q: When is Geffy 250 Mg Tablet contraindicated?

A: This medication is contraindicated in individuals with known hypersensitivity to gefitinib or any component of the formula. Always consult your doctor before starting the tablet.

Q: Where should Geffy 250 Mg Tablet be stored?

A: Store the tablets in a cool, dry location, away from direct sunlight, to preserve their potency and stability throughout the 24-month shelf life.

Q: What precautions should be observed during Geffy 250 Mg Tablet usage?

A: Patients with liver or kidney impairment, as well as pregnant or lactating women, should only use Geffy after consulting their physician to ensure safety and appropriateness of therapy.

Q: How does Geffy 250 Mg Tablet work in treating cancer?

A: Geffy acts as a targeted tyrosine kinase inhibitor, selectively inhibiting EGFR-TK enzymatic activity in cancer cells, which impedes tumor growth and offers a focused approach to NSCLC therapy.

Tell us about your requirement